HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fluoxetine in borderline personality disorder.

Abstract
1. Twelve patients with borderline personality disorder and not suffering a major depression were treated with fluoxetine, a selective serotonin reuptake inhibitor, in an open label trial. All of the patients improved, and 75% were rated as much or very much improved. 2. Treatment was generally very well tolerated, but careful dosage titration was important in some patients, especially to manage agitation. 3. Improvement has been maintained with continued treatment throughout the follow-up period which ranged up to six months. 4. Incidental findings suggest fluoxetine may also be of use in treating substance abuse, attention deficit hyperactivity disorder, late luteal phase dysphoria disorder, dysthymic and cyclothymic disorders, and seasonal pattern depression. 5. These preliminary results support the hypothesis that borderline personality disorder may be related to a central serotonergic deficit.
AuthorsM J Norden
JournalProgress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 13 Issue 6 Pg. 885-93 ( 1989) ISSN: 0278-5846 [Print] England
PMID2813806 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fluoxetine
Topics
  • Adult
  • Borderline Personality Disorder (drug therapy, psychology)
  • Female
  • Fluoxetine (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: